DIANA NICHOLS: Open Payments
NPI 1194009480 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,209 in 11 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $803 · 2025 $1,209
Food & beverage: $1,209
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $229 |
| Corcept Therapeutics | 2 | $206 |
| PharmaEssentia USA Corporation | 1 | $132 |
| Supernus Pharmaceuticals, Inc. | 1 | $125 |
| Gilead Sciences, Inc. | 1 | $122 |
| Noven Therapeutics, LLC | 1 | $107 |
| Xeris Pharmaceuticals, Inc. | 1 | $107 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $96 |
| Eisai Inc. | 1 | $84 |
Products named: Korlym, BESREMI, Qelbree, Livdelzi, Xelstrym, RECORLEV, JOURNAVX, Leqembi.
Industry payments across TX — which companies pay providers there.
